## Abstract A total of 5,209 asymptomatic, middle‐aged subjects, whose serum pepsinogen (PG) and __Helicobacter pylori__ antibody levels had been assessed, were followed for 10 years. Subjects with positive serum __H. pylori__ antibodies (>50 U/mL) had an increased cancer risk (HR = 3.48, 95% CI =
Prevalence of Helicobacter pylori in asymptomatic subjects—A nested PCR based study
✍ Scribed by Shrutkirti Mishra; Varsha Singh; G.R.K. Rao; V.K. Dixit; A.K. Gulati; Gopal Nath
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 150 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1567-1348
No coin nor oath required. For personal study only.
✦ Synopsis
The aim of the study was to see the prevalence of Helicobacter pylori in asymptomatic children and adults by using nested PCR which is considered to be more specific than serological methods. Saliva and stool samples of 137 healthy children (aged 8 months to 16 y) and 108 asymptomatic adults (aged 17-60 y) were collected. PCR with primers targeting Hsp60 gene sequence of H. pylori was used. H. pylori positivity with nested PCR was observed in 45.7% (112/245) of the saliva and 42.8% (105/245) of the stool specimens. Prevalence of H. pylori in saliva was found to be 2.1%, 22.7%, 55.9%, 56.0%, 68.9% and 62.9% in the age groups of < 5 y, 6-10 y, 11-16 y, 17-30 y , 31-45 y and 45-60 y, respectively. The detection rates in stool were 4.25% in < 5 y, 13.64% in 6-10 y, 50% in 11-16 y, 64% in 17-30 y, 58.62% in 31-45 y and 61.1% in 45-60 y of age groups. The most favourable age group for acquiring the infection was 11-16 y. H. pylori positivity increased with lowering of socioeconomic status. There was no gender bias in prevalence of the bacterium.
📜 SIMILAR VOLUMES
## Abstract To investigate the relationship between __p16__ methylation and __Helicobacter pylori__ infection in precancerous gastric lesions, a population‐based study was conducted in Linqu County, a high‐risk area of gastric cancer in China. Methylation status of __p16__ was evaluated by methylat
## Abstract ## Objective Most of the data about the prevalence of pulmonary arterial hypertension (PAH) are from tertiary centers that are biased toward seeing more severe cases; therefore, the true prevalence of PAH among patients with connective tissue disease is unknown. We sought to determine